Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association With Biomarker of Bone Formation

Calcified Tissue International - United States
doi 10.1007/s00223-011-9478-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Oral Phosphorus Supplementation Secondarily Increases Circulating Fibroblast Growth Factor 23 Levels at Least Partially via Stimulation of Parathyroid Hormone Secretion

Journal of Nutritional Science and Vitaminology
MedicineNutritionDietetics
2014English

Parathyroid Hormone Regulates Fibroblast Growth Factor-23 in a Mouse Model of Primary Hyperparathyroidism

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2007English

Elevated Levels of Circulating Fibroblast Growth Factor 23 With Hypercalcemia Following Discontinuation of Denosumab

Endocrine Journal
EndocrinologyMetabolismDiabetes
2020English

Genetic Variants Associated With Circulating Fibroblast Growth Factor 23

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2018English

Parathyroid Hormone Reduces Fractures in Postmenopausal Women With Osteoporosis

BMJ
2006English

Fibroblast Growth Factor-23-Mediated Inhibition of Renal Phosphate Transport in Mice Requires Sodium-Hydrogen Exchanger Regulatory Factor-1 (NHERF-1) and Synergizes With Parathyroid Hormone

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Intermittent Parathyroid Hormone After Prolonged Alendronate Treatment Induces Substantial New Bone Formation and Increases Bone Tissue Heterogeneity in Ovariectomized Rats

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2017English

The Biomarker Niche for Fibroblast Growth Factor 23 Testing in CKD

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2014English

Recombinant Human Parathyroid Hormone Related Protein 1-34 and 1-84 and Their Roles in Osteoporosis Treatment

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy